Profound Depletion of HIV-1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection

被引:82
作者
Schmid, Adrian [1 ]
Gianella, Sara [1 ]
von Wyl, Viktor [1 ]
Metzner, Karin J. [1 ]
Scherrer, Alexandra U. [1 ]
Niederost, Barbara [1 ]
Althaus, Claudia F. [1 ]
Rieder, Philip [1 ]
Grube, Christina [1 ]
Joos, Beda [1 ]
Weber, Rainer [1 ]
Fischer, Marek [1 ]
Gunthard, Huldrych F. [1 ]
机构
[1] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
来源
PLOS ONE | 2010年 / 5卷 / 10期
基金
瑞士国家科学基金会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD MONONUCLEAR-CELLS; STRUCTURED TREATMENT INTERRUPTIONS; CD4(+) T-LYMPHOCYTES; PERIPHERAL-BLOOD; GENE-EXPRESSION; PLASMA VIREMIA; VIRAL REPLICATION; IMMUNE-RESPONSES; IN-VIVO;
D O I
10.1371/journal.pone.0013310
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Although combination antiretroviral therapy (cART) initiated in the acute phase of HIV-1 infection may prevent expansion of the latent reservoir, its benefits remain controversial. In the current study, HIV-1 RNA transcription patterns in peripheral blood mononuclear cells (PBMC) were monitored during acute cART to assess the effect of early treatment on cellular viral reservoirs. Methodology/Principal Findings: Acutely HIV-1 infected patients (n = 24) were treated within 3-15 weeks after infection. Patients elected to cease treatment after >= 1 year of therapy. HIV-1 DNA (vDNA), HIV-1 RNA species expressed both in latently and productively infected cells, unspliced (UsRNA), multiply spliced (MsRNA-tatrev; MsRNA-nef), and PBMC-associated extracellular virion RNA (vRex), expressed specifically by productively infected cells, were quantified in PBMC by patient matched real-time PCR prior, during and post cART. In a matched control-group of patients on successful cART started during chronic infection (n = 15), UsRNA in PBMC and vDNA were measured cross-sectionally. In contrast to previous reports, PBMC-associated HIV-1 RNAs declined to predominantly undetectable levels on cART. After cART cessation, UsRNA, vRex, and MsRNA-tatrev rebounded to levels not significantly different to those at baseline (p>0.1). In contrast, MsRNA-nef remained significantly lower as compared to pretreatment (p = 0.015). UsRNA expressed at the highest levels of all viral RNAs, was detectable on cART in 42% of patients with cART initiated during acute infection as opposed to 87% of patients on cART initiated during chronic infection (Fisher's exact test; p = 0.008). Accordingly, UsRNA levels were 105-fold lower in the acute as compared to the chronic group. Conclusion: Early intervention resulted in profound depletion of PBMC expressing HIV-1 RNA. This is contrary to chronically infected patients who predominantly showed continuous UsRNA expression on cART. Thus, antiretroviral treatment initiated during the acute phase of infection prevented establishment or expansion of long-lived transcriptionally active viral cellular reservoirs in peripheral blood.
引用
收藏
页数:9
相关论文
共 73 条
[1]   HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus [J].
Altfeld, M ;
Allen, TM ;
Yu, XG ;
Johnston, MN ;
Agrawal, D ;
Korber, BT ;
Montefiori, DC ;
O'Connor, DH ;
Davis, BT ;
Lee, PK ;
Maier, EL ;
Harlow, J ;
Goulder, PJR ;
Brander, C ;
Rosenberg, ES ;
Walker, BD .
NATURE, 2002, 420 (6914) :434-439
[2]   Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection [J].
Altfeld, M ;
Rosenberg, ES ;
Shankarappa, R ;
Mukherjee, JS ;
Hecht, FM ;
Eldridge, RL ;
Addo, MM ;
Poon, SH ;
Phillips, MN ;
Robbins, GK ;
Sax, PE ;
Boswell, S ;
Kahn, JO ;
Brander, C ;
Goulder, PJR ;
Levy, JA ;
Mullins, JI ;
Walker, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :169-180
[3]   Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performance [J].
Althaus, Claudia F. ;
Gianellaa, Sara ;
Rieder, Philip ;
von Wyl, Viktor ;
Kouyos, Roger D. ;
Niederoest, Barbara ;
Schmid, Adrian ;
Metzner, Karin J. ;
Joos, Beda ;
Guenthard, Huldrych F. ;
Fischer, Marek .
JOURNAL OF VIROLOGICAL METHODS, 2010, 165 (02) :151-160
[4]   Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects [J].
Anton, PA ;
Mitsuyasu, RT ;
Deeks, SG ;
Scadden, DT ;
Wagner, B ;
Huang, C ;
Macken, C ;
Richman, DD ;
Christopherson, C ;
Borellini, F ;
Lazar, R ;
Hege, KM .
AIDS, 2003, 17 (01) :53-63
[5]   Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model [J].
Barber, SA ;
Gama, L ;
Dudaronek, JM ;
Voelker, T ;
Tarwater, PM ;
Clements, JE .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (07) :963-970
[6]   PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells [J].
Christopherson, C ;
Kidane, Y ;
Conway, B ;
Krowka, J ;
Sheppard, H ;
Kwok, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :630-634
[7]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[8]   HIV-1 elite controllers: Beware of super-infections [J].
Clerc, Olivier ;
Colombo, Sara ;
Yerly, Sabine ;
Telenti, Amalio ;
Cavassini, Matthias .
JOURNAL OF CLINICAL VIROLOGY, 2010, 47 (04) :376-378
[9]   COMBINED DRUG TREATMENT OF TUBERCULOSIS .1. PREVENTION OF EMERGENCE OF MUTANT POPULATIONS OF TUBERCLE BACILLI RESISTANT TO BOTH STREPTOMYCIN AND ISONIAZID INVITRO [J].
COHN, ML ;
MIDDLEBROOK, G ;
RUSSELL, WF .
JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (08) :1349-1355
[10]   Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy [J].
Craigo, JK ;
Patterson, BK ;
Paranjpe, S ;
Kulka, K ;
Ding, M ;
Mellors, J ;
Montelaro, RC ;
Gupta, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (11) :1196-1209